{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T15:07:49Z","timestamp":1794496069957,"version":"4.9.1"},"publisher-location":"Berlin, Heidelberg","reference-count":122,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"value":"9783662446041","type":"print"},{"value":"9783662446058","type":"electronic"}],"license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015]]},"DOI":"10.1007\/978-3-662-44605-8_16","type":"book-chapter","created":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T04:49:24Z","timestamp":1428641364000},"page":"291-314","source":"Crossref","is-referenced-by-count":106,"title":["Targeting Itch with Ligands Selective for \u03ba Opioid Receptors"],"prefix":"10.1007","author":[{"given":"Alan","family":"Cowan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George B.","family":"Kehner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saadet","family":"Inan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"16_CR1","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2340\/00015555-1879","volume":"95","author":"T Akiyama","year":"2015","unstructured":"Akiyama T, Carstens MI, Piecha D, Steppan S, Carstens E (2015) Nalfurafine suppresses pruritogen- and touch-evoked scratching behavior in models of acute and chronic itch in mice. Acta Derm Venereol 95:147\u2013150","journal-title":"Acta Derm Venereol"},{"key":"16_CR2","doi-asserted-by":"crossref","first-page":"18396","DOI":"10.1073\/pnas.0910180106","volume":"106","author":"JV Aldrich","year":"2009","unstructured":"Aldrich JV, Patkar KA, McLaughlin JP (2009) Zyklophin, a systemically active selective kappa opioid receptor peptide antagonist with short duration of action. Proc Natl Acad Sci 106:18396\u201318401","journal-title":"Proc Natl Acad Sci"},{"key":"16_CR3","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/BF02145873","volume":"27","author":"A Anastasi","year":"1971","unstructured":"Anastasi A, Erspamer V, Bucci M (1971) Isolation and structure of bombesin and alytesin, two analogous active peptides from the skin of the European amphibians Bombina and Alytes. Experientia 27:166\u2013167","journal-title":"Experientia"},{"key":"16_CR4","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1016\/j.peptides.2011.09.003","volume":"32","author":"T Andoh","year":"2011","unstructured":"Andoh T, Kuwazono T, Lee J-B, Kuraishi Y (2011) Gastrin-releasing peptide induces itch-related responses through mast cell degranulation in mice. Peptides 32:2098\u20132103","journal-title":"Peptides"},{"key":"16_CR5","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1111\/j.1476-5381.1994.tb17142.x","volume":"113","author":"A Barber","year":"1994","unstructured":"Barber A, Bartoszyk GD, Bender HM, Gottschlich R, Greiner HE, Harting J, Mauler F, Minck K-O, Murray RD, Simon M, Seyfried CA (1994) A pharmacological profile of the novel, peripherally-selective \u03ba-opioid receptor agonist, EMD 61753. Br J Pharmacol 113:1317\u20131327","journal-title":"Br J Pharmacol"},{"key":"16_CR6","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/0014-2999(87)90397-9","volume":"144","author":"PJ Birch","year":"1987","unstructured":"Birch PJ, Hayes AG, Sheehan MJ, Tyers MB (1987) Norbinaltorphimine: antagonist profile at \u03ba opioid receptors. Eur J Pharmacol 144:405\u2013408","journal-title":"Eur J Pharmacol"},{"key":"16_CR7","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.pbb.2008.12.023","volume":"92","author":"SL Briggs","year":"2009","unstructured":"Briggs SL, Rech RH (2009) Antinociceptive interactions of mu- and kappa-opioid agonists in the colorectal distension assay in rats. Pharmacol Biochem Behav 92:343\u2013350","journal-title":"Pharmacol Biochem Behav"},{"key":"16_CR8","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/BF02245071","volume":"115","author":"JH Broadbear","year":"1994","unstructured":"Broadbear JH, Negus SS, Butelman ER, de Costa BR, Woods JH (1994) Differential effects of systemically administered nor-binaltorphimine (nor-BNI) on \u03ba-opioid agonists in the mouse writhing assay. Psychopharmacology (Berl) 115:311\u2013319","journal-title":"Psychopharmacology (Berl)"},{"key":"16_CR9","doi-asserted-by":"crossref","first-page":"29803","DOI":"10.1074\/jbc.M705540200","volume":"282","author":"MR Bruchas","year":"2007","unstructured":"Bruchas MR, Yang T, Schreiber S, DeFino M, Kwan SC, Li S, Chavkin C (2007) Long-acting \u03ba opioid antagonists disrupt receptor signaling and produce noncompetitive effects by activating c-Jun N-terminal kinase. J Biol Chem 282:29803\u201329811","journal-title":"J Biol Chem"},{"key":"16_CR11","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1021\/jm301783x","volume":"56","author":"FI Carroll","year":"2013","unstructured":"Carroll FI, Carlezon WA (2013) Development of \u03ba opioid receptor antagonists. J Med Chem 56:2178\u20132195","journal-title":"J Med Chem"},{"key":"16_CR12","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ejphar.2004.08.028","volume":"501","author":"I Carroll","year":"2004","unstructured":"Carroll I, Thomas JB, Dykstra LA, Granger AL, Allen RM, Howard JL, Pollard GT, Aceto MD, Harris LS (2004) Pharmacological properties of JDTic: a novel \u03ba-opioid receptor antagonist. Eur J Pharmacol 501:111\u2013119","journal-title":"Eur J Pharmacol"},{"key":"16_CR13","first-page":"490","volume-title":"The essence of analgesia and analgesics","author":"D Chalmers","year":"2011","unstructured":"Chalmers D (2011) Peripheral kappa agonists. In: Sinatra RS, Jahr JS, Watkins-Pitchford JM (eds) The essence of analgesia and analgesics. Cambridge University Press, New York, pp 490\u2013491"},{"key":"16_CR14","volume-title":"The book of skin","author":"S Connor","year":"2004","unstructured":"Connor S (2004) The book of skin. Reaktion Books Ltd, London, UK"},{"key":"16_CR15","first-page":"427","volume-title":"Narcotic antagonists","author":"A Cowan","year":"1973","unstructured":"Cowan A (1973) Evaluation in nonhuman primates: evaluation of the physical dependence capacities of oripavine-thebaine partial agonists in patas monkeys. In: Braude MC, Harris LS, May EL, Smith JP, Villarreal JE (eds) Narcotic antagonists. Raven, New York, pp 427\u2013438"},{"key":"16_CR16","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1749-6632.1988.tb23888.x","volume":"547","author":"A Cowan","year":"1988","unstructured":"Cowan A (1988) Behavioral effects of bombesin. Ann NY Acad Sci 547:204\u2013209","journal-title":"Ann NY Acad Sci"},{"key":"16_CR17","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0165-6147(86)90257-9","volume":"7","author":"A Cowan","year":"1986","unstructured":"Cowan A, Gmerek DE (1986) In-vivo studies on kappa opioid receptors. Trends Pharmacol Sci 7:69\u201372","journal-title":"Trends Pharmacol Sci"},{"key":"16_CR18","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/978-1-59745-197-0_28","volume-title":"Opiate receptors and antagonists: From bench to clinic","author":"A Cowan","year":"2009","unstructured":"Cowan A, Inan S (2009) Kappa-opioid antagonists as pruritogenic agents. In: Dean R, Bilsky EJ, Negus SS (eds) Opiate receptors and antagonists: From bench to clinic. Humana \/Springer Press, New York, pp 541\u2013549"},{"key":"16_CR19","first-page":"612","volume":"93","author":"A Cowan","year":"2013","unstructured":"Cowan A, Inan S (2013) Enigmatic aspects of 5\u2032-GNTI-induced compulsive scratching in mice. Acta Derm Venereol 93:612","journal-title":"Acta Derm Venereol"},{"issue":"Suppl","key":"16_CR20","first-page":"169P","volume":"122","author":"A Cowan","year":"1997","unstructured":"Cowan A, Kehner GB (1997) Antagonism by opioids of compound 48\/80-induced scratching in mice. Br J Pharmacol 122(Suppl):169P","journal-title":"Br J Pharmacol"},{"key":"16_CR21","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0024-3205(85)90416-3","volume":"37","author":"A Cowan","year":"1985","unstructured":"Cowan A, Khunawat P, Zhu XZ, Gmerek DE (1985) Effects of bombesin on behavior. Life Sci 37:135\u2013145612","journal-title":"Life Sci"},{"issue":"Suppl 1","key":"16_CR22","first-page":"A51","volume":"44","author":"A Cowan","year":"2002","unstructured":"Cowan A, Inan S, Kehner GB (2002) GNTI, a kappa receptor antagonist, causes compulsive scratching in mice. Pharmacologist 44(Suppl 1):A51","journal-title":"Pharmacologist"},{"key":"16_CR23","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jaad.2005.12.010","volume":"54","author":"AG Dawn","year":"2006","unstructured":"Dawn AG, Yosipovitch G (2006) Butorphanol for treatment of intractable pruritus. J Am Acad Dermatol 54:527\u2013531","journal-title":"J Am Acad Dermatol"},{"key":"16_CR24","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.neulet.2014.01.022","volume":"563","author":"KM DiMattio","year":"2014","unstructured":"DiMattio KM, Yakovleva TV, Aldrich JV, Cowan A, Liu-Chen L-Y (2014) Zyklophin, a short-acting kappa opioid antagonist, induces scratching in mice. Neurosci Lett 563:155\u2013159","journal-title":"Neurosci Lett"},{"key":"16_CR25","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jaci.2006.08.034","volume":"119","author":"PJ Dunford","year":"2007","unstructured":"Dunford PJ, Williams KN, Desai PJ, Karlsson L, McQueen D, Thurmond RL (2007) Histamine H4 receptor antagonists are superior to traditional antihistamines in the attenuation of experimental pruritus. J Allergy Clin Immunol 119:176\u2013183","journal-title":"J Allergy Clin Immunol"},{"key":"16_CR26","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0885-3924(96)00154-6","volume":"12","author":"E Dunteman","year":"1996","unstructured":"Dunteman E, Karanikolas M, Filos KS (1996) Transnasal butorphanol for the treatment of opioid-induced pruritus unresponsive to antihistamines. J Pain Symptom Manage 12:255\u2013260","journal-title":"J Pain Symptom Manage"},{"key":"16_CR27","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0304-3959(02)00259-2","volume":"101","author":"JC Eisenach","year":"2003","unstructured":"Eisenach JC, Carpenter R, Curry R (2003) Analgesia from a peripherally active \u03ba-opioid receptor agonist in patients with chronic pancreatitis. Pain 101:89\u201395","journal-title":"Pain"},{"key":"16_CR28","first-page":"30","volume":"316","author":"T Endoh","year":"1992","unstructured":"Endoh T, Matsuura H, Tanaka C, Nagase H (1992) Nor-binaltorphimine: a potent and selective \u03ba-opioid receptor antagonist with long-lasting activity in vivo. Arch Int Pharmacodyn Ther 316:30\u201342","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"16_CR29","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/0196-9781(83)90089-X","volume":"4","author":"DE Gmerek","year":"1983","unstructured":"Gmerek DE, Cowan A (1983a) Studies on bombesin-induced grooming in rats. Peptides 4:907\u2013913","journal-title":"Peptides"},{"key":"16_CR30","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1365-2133.1983.tb07091.x","volume":"109","author":"DE Gmerek","year":"1983","unstructured":"Gmerek DE, Cowan A (1983b) Bombesin\u2014a central mediator of pruritus? Br J Dermatol 109:239","journal-title":"Br J Dermatol"},{"key":"16_CR31","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0160-5402(83)90073-6","volume":"10","author":"DE Gmerek","year":"1983","unstructured":"Gmerek DE, Cowan A (1983c) An animal model for preclinical screening of systemic antipruritic agents. J Pharmacol Methods 10:107\u2013112","journal-title":"J Pharmacol Methods"},{"key":"16_CR32","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0022-3565(25)21347-7","volume":"230","author":"DE Gmerek","year":"1984","unstructured":"Gmerek DE, Cowan A (1984) In vivo evidence for benzomorphan-selective receptors in rats. J Pharmacol Exp Ther 230:110\u2013115","journal-title":"J Pharmacol Exp Ther"},{"key":"16_CR33","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0014-2999(83)90451-X","volume":"94","author":"DE Gmerek","year":"1983","unstructured":"Gmerek DE, Cowan A, Vaught JL (1983) Intrathecal bombesin in rats: effects on behavior and gastrointestinal transit. Eur J Pharmacol 94:141\u2013143","journal-title":"Eur J Pharmacol"},{"key":"16_CR34","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0022-3565(25)39099-3","volume":"242","author":"DE Gmerek","year":"1987","unstructured":"Gmerek DE, Dykstra LA, Woods JH (1987) Kappa opioids in rhesus monkeys. III. Dependence associated with chronic administration. J Pharmacol Exp Ther 242:428\u2013436","journal-title":"J Pharmacol Exp Ther"},{"key":"16_CR35","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1744-8069-10-44","volume":"10","author":"SC Goswami","year":"2014","unstructured":"Goswami SC, Thierry-Mieg D, Thierry-Mieg J, Mishra S, Hoon MA, Mannes AJ, Iadarola MJ (2014) Itch-associated peptides: RNA-Seq and bioinformatic analysis of natriuretic precursor peptide B and gastrin releasing peptide in dorsal root and trigeminal ganglia, and the spinal cord. Mol Pain 10:44","journal-title":"Mol Pain"},{"key":"16_CR36","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.pain.2006.03.023","volume":"124","author":"AD Green","year":"2006","unstructured":"Green AD, Young KK, Lehto SG, Smith SB, Mogil JS (2006) Influence of genotype, dose and sex on pruritogen-induced scratching behavior in the mouse. Pain 124:50\u201358","journal-title":"Pain"},{"key":"16_CR37","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1021\/jm00163a047","volume":"33","author":"PR Halfpenny","year":"1990","unstructured":"Halfpenny PR, Horwell DC, Hughes J, Hunter JC, Rees DC (1990) Highly selective \u03ba-opioid analgesics. 3. Synthesis and structure-activity relationships of novel N-[2-(pyrrolidinyl)-4- or -5-substituted-cyclohexyl]arylacetamide derivatives. J Med Chem 33:286\u2013291","journal-title":"J Med Chem"},{"key":"16_CR38","first-page":"634","volume":"93","author":"A Hawi","year":"2013","unstructured":"Hawi A, Hunter R, Morford L, Sciascia T (2013) Nalbuphine attenuates itch in the substance P-induced mouse model. Acta Derm Venereol 93:634","journal-title":"Acta Derm Venereol"},{"key":"16_CR39","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/S0022-3565(25)11434-1","volume":"260","author":"P Horan","year":"1992","unstructured":"Horan P, Taylor J, Yamamura HI, Porreca F (1992) Extremely long-lasting antagonistic actions of norbinaltorphimine (nor-BNI) in the mouse tail-flick test. J Pharmacol Exp Ther 260:1237\u20131243","journal-title":"J Pharmacol Exp Ther"},{"key":"16_CR40","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1476-5381.1990.tb12110.x","volume":"101","author":"JC Hunter","year":"1990","unstructured":"Hunter JC, Leighton GE, Meecham KG, Boyle SJ, Horwell DC, Rees DC, Hughes J (1990) CI-977, a novel and selective agonist for the \u03ba-opioid receptor. Br J Pharmacol 101:183\u2013189","journal-title":"Br J Pharmacol"},{"key":"16_CR41","unstructured":"Inan S (2010) Pharmacological and neuroanatomical analysis of GNTI-induced repetitive behavior in mice. PhD thesis, Temple University, Philadelphia"},{"key":"16_CR42","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ejphar.2004.09.010","volume":"502","author":"S Inan","year":"2004","unstructured":"Inan S, Cowan A (2004) Kappa opioid agonists suppress chloroquine-induced scratching in mice. Eur J Pharmacol 502:233\u2013237","journal-title":"Eur J Pharmacol"},{"key":"16_CR43","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.pbb.2006.07.004","volume":"85","author":"S Inan","year":"2006","unstructured":"Inan S, Cowan A (2006) Nalfurafine, a kappa opioid receptor agonist, inhibits scratching behavior secondary to cholestasis induced by chronic ethynylestradiol injections in rats. Pharmacol Biochem Behav 85:39\u201343","journal-title":"Pharmacol Biochem Behav"},{"key":"16_CR44","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ejphar.2009.06.026","volume":"616","author":"S Inan","year":"2009","unstructured":"Inan S, Dun NJ, Cowan A (2009a) Inhibitory effect of lidocaine on pain and itch using formalin-induced nociception and 5\u2032-guanidinonaltrindole-induced scratching models in mice: behavioral and neuroanatomical evidence. Eur J Pharmacol 616:141\u2013146","journal-title":"Eur J Pharmacol"},{"key":"16_CR45","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.neuroscience.2009.06.016","volume":"163","author":"S Inan","year":"2009","unstructured":"Inan S, Dun NJ, Cowan A (2009b) Nalfurafine prevents 5\u2032-guanidinonaltrindole- and compound 48\/80-induced spinal c-fos expression and attenuates 5\u2032-guanidinonaltrindole-elicited scratching behavior in mice. Neuroscience 163:23\u201333","journal-title":"Neuroscience"},{"key":"16_CR46","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00210-008-0358-8","volume":"379","author":"S Inan","year":"2009","unstructured":"Inan S, Lee DY-W, Liu-Chen L-Y, Cowan A (2009c) Comparison of the diuretic effects of chemically diverse kappa opioid agonists in rats: nalfurafine, U50,488H, and salvinorin A. Naunyn Schmiedebergs Arch Pharmacol 379:263\u2013270","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"16_CR47","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.peptides.2010.11.022","volume":"32","author":"S Inan","year":"2011","unstructured":"Inan S, Dun NJ, Cowan A (2011) Investigation of gastrin-releasing peptide as a mediator for 5\u2032-guanidinonaltrindole-induced compulsive scratching in mice. Peptides 32:286\u2013292","journal-title":"Peptides"},{"key":"16_CR48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/pr.107.07108","volume":"60","author":"RT Jensen","year":"2008","unstructured":"Jensen RT, Battey JF, Spindel ER, Benya RV (2008) International Union of Pharmacology. LXVIII. Mammalian bombesin receptors: nomenclature, distribution, pharmacology, signaling, and functions in normal and disease states. Pharmacol Rev 60:1\u201342","journal-title":"Pharmacol Rev"},{"key":"16_CR49","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0014-2999(00)00208-9","volume":"396","author":"RM Jones","year":"2000","unstructured":"Jones RM, Portoghese PS (2000) 5\u2032-Guanidinonaltrindole, a highly selective and potent \u03ba-opioid receptor antagonist. Eur J Pharmacol 396:49\u201352","journal-title":"Eur J Pharmacol"},{"key":"16_CR50","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0014-2999(01)00941-4","volume":"418","author":"J Kamei","year":"2001","unstructured":"Kamei J, Nagase H (2001) Norbinaltorphimine, a selective \u03ba-opioid receptor antagonist, induces an itch-associated response in mice. Eur J Pharmacol 418:141\u2013145","journal-title":"Eur J Pharmacol"},{"key":"16_CR51","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.neuron.2014.02.046","volume":"82","author":"AP Kardon","year":"2014","unstructured":"Kardon AP, Polg\u00e1r E, Hachisuka J, Snyder LM, Cameron D, Savage S, Cai X, Kamup S, Fan CR, Hemenway GM, Bernard CS, Schwartz ES, Nagase H, Schwarzer C, Watanabe M, Furuta T, Kaneko T, Koerber HR, Todd AJ, Ross SE (2014) Dynorphin acts as a neuromodulator to inhibit itch in the dorsal horn of the spinal cord. Neuron 82:573\u2013586","journal-title":"Neuron"},{"key":"16_CR52","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0028-3908(80)90181-1","volume":"19","author":"R Katz","year":"1980","unstructured":"Katz R (1980) Grooming elicited by intracerebroventricular bombesin and eledoisin in the mouse. Neuropharmacology 19:143\u2013146","journal-title":"Neuropharmacology"},{"key":"16_CR53","unstructured":"Kehner GB (2002) Studies on the pharmacological relationship between pain and pruritus. PhD thesis, Temple University, Philadelphia 226"},{"key":"16_CR54","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.neulet.2013.07.040","volume":"552","author":"S Kishioka","year":"2013","unstructured":"Kishioka S, Kiguchi N, Kobayashi Y, Yamamoto C, Saika F, Wakida N, Ko M-C, Woods JH (2013) Pharmacokinetic evidence for the long-lasting effect of nor-binaltorphimine, a potent kappa opioid receptor antagonist, in mice. Neurosci Lett 552:98\u2013102","journal-title":"Neurosci Lett"},{"key":"16_CR55","doi-asserted-by":"crossref","unstructured":"Ko M-C (2015) Neuraxial opioid-induced itch and its pharmacological antagonism. Handbook of Experimental Pharmacology 226:315\u2013335","DOI":"10.1007\/978-3-662-44605-8_17"},{"key":"16_CR56","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0006-8993(03)02938-X","volume":"982","author":"MCH Ko","year":"2003","unstructured":"Ko MCH, Willmont KJ, Lee H, Flory GS, Woods JH (2003) Ultra-low antagonism of kappa opioid agonist-induced diuresis by intracisternal nor-binaltorphimine in monkeys. Brain Res 982:38\u201344","journal-title":"Brain Res"},{"key":"16_CR57","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1124\/jpet.114.215749","volume":"350","author":"A Kollmeier","year":"2014","unstructured":"Kollmeier A, Francke K, Chen B, Dunford PJ, Greenspan AJ, Xia Y, Xu XL, Zhou B, Thurmond RL (2014) The histamine H4 receptor antagonist, JNJ 39758979, is effective in reducing histamine-induced pruritus in a randomized clinical study in healthy subjects. J Pharmacol Exp Ther 350:181\u2013187","journal-title":"J Pharmacol Exp Ther"},{"key":"16_CR58","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/0006-8993(82)90511-X","volume":"242","author":"PJ Kulkosky","year":"1982","unstructured":"Kulkosky PJ, Gibbs J, Smith GP (1982) Feeding suppression and grooming repeatedly elicited by intraventricular bombesin. Brain Res 242:194\u2013196","journal-title":"Brain Res"},{"key":"16_CR59","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1093\/ndt\/gfp588","volume":"25","author":"H Kumagai","year":"2010","unstructured":"Kumagai H, Ebata T, Takamori K, Muramatsu T, Nakamoto H, Suzuki H (2010) Effect of a novel kappa-receptor agonist, nalfurafine hydrochloride, on severe itch in 337 haemodialysis patients: a phase III, randomized, double-blind, placebo-controlled study. Nephrol Dial Transplant 25:1251\u20131257","journal-title":"Nephrol Dial Transplant"},{"key":"16_CR60","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000341268","volume":"36","author":"H Kumagai","year":"2012","unstructured":"Kumagai H, Ebata T, Takamori K, Miyasato K, Muramatsu T, Nakamoto H, Kurihara M, Yanagita T, Suzuki H (2012) Efficacy and safety of a novel \u03ba-agonist for managing intractable pruritus in dialysis patients. Am J Nephrol 36:175\u2013183","journal-title":"Am J Nephrol"},{"key":"16_CR61","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/S0022-3565(25)24372-5","volume":"238","author":"KM Kumor","year":"1986","unstructured":"Kumor KM, Haertzen CA, Johnson RE, Kocher T, Jasinski D (1986) Human psychopharmacology of ketocyclazocine as compared with cyclazocine, morphine and placebo. J Pharmacol Exp Ther 238:960\u2013968","journal-title":"J Pharmacol Exp Ther"},{"key":"16_CR62","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0014-2999(94)00780-B","volume":"275","author":"Y Kuraishi","year":"1995","unstructured":"Kuraishi Y, Nagasawa T, Hayashi K, Satoh M (1995) Scratching behavior induced by pruritogenic but not by algesiogenic agents in mice. Eur J Pharmacol 275:229\u2013233","journal-title":"Eur J Pharmacol"},{"key":"16_CR63","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/01.anes.0000278876.20263.a7","volume":"107","author":"H Lee","year":"2007","unstructured":"Lee H, Naughton NN, Woods JH, Ko M-C (2007) Effects of butorphanol on morphine-induced itch and analgesia in primates. Anesthesiology 107:478\u2013485","journal-title":"Anesthesiology"},{"key":"16_CR64","first-page":"4","volume":"10","author":"X-Y Liu","year":"2014","unstructured":"Liu X-Y, Wan L, Huo F-Q, Barry D, Li H, Zhao Z-Q, Chen Z-F (2014) B-type natriuretic peptide is neither itch-specific nor functions upstream of the GRP-GRPR signaling pathway. Mol Pain 10:4","journal-title":"Mol Pain"},{"key":"16_CR65","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S0022-3565(24)34907-9","volume":"290","author":"H Machelska","year":"1999","unstructured":"Machelska H, Pfl\u00fcger M, Weber W, Piranvisseh-V\u00f6lk M, Daubert JD, DeHaven R, Stein C (1999) Peripheral effects of the \u03ba-opioid agonist EMD 61753 on pain and inflammation in rats and humans. J Pharmacol Exp Ther 290:354\u2013361","journal-title":"J Pharmacol Exp Ther"},{"key":"16_CR66","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0022-3565(25)30536-7","volume":"197","author":"WR Martin","year":"1976","unstructured":"Martin WR, Eades CG, Thompson JA, Huppler RE, Gilbert PE (1976) The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog. J Pharmacol Exp Ther 197:517\u2013532","journal-title":"J Pharmacol Exp Ther"},{"key":"16_CR67","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0014-2999(93)90860-K","volume":"238","author":"A Masui","year":"1993","unstructured":"Masui A, Kato N, Itoshima T, Tsunashima K, Nakajima T, Yanaihara N (1993) Scratching behavior induced by bombesin-related peptides. Comparison of bombesin, gastrin-releasing peptide and phyllolitorins. Eur J Pharmacol 238:297\u2013301","journal-title":"Eur J Pharmacol"},{"key":"16_CR68","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.pbb.2005.12.011","volume":"83","author":"CR McCurdy","year":"2006","unstructured":"McCurdy CR, Sufka KJ, Smith GH, Warnick JE, Nieto MJ (2006) Antinociceptive profile of salvinorin A, a structurally unique kappa opioid receptor agonist. Pharmacol Biochem Behav 83:109\u2013113","journal-title":"Pharmacol Biochem Behav"},{"key":"16_CR69","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1124\/mol.111.074195","volume":"80","author":"EJ Melief","year":"2011","unstructured":"Melief EJ, Miyatake M, Carroll FI, B\u00e9guin C, Carlezon WA, Cohen BM, Grimwood S, Mitch CH, Rorick-Kehn L, Chavkin C (2011) Duration of action of a broad range of selective \u03ba-opioid receptor antagonists is positively correlated with c-Jun N-terminal kinase-1 activation. Mol Pharmacol 80:920\u2013929","journal-title":"Mol Pharmacol"},{"key":"16_CR70","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/978-0-387-76678-2_25","volume-title":"Drug addiction: from basic research to therapy","author":"MD Metcalf","year":"2008","unstructured":"Metcalf MD, Coop A (2008) Kappa opioid antagonists: past successes and future prospects. In: Rapaka RS, Sad\u00e9e W (eds) Drug addiction: from basic research to therapy. Springer, New York, pp 395\u2013431"},{"key":"16_CR71","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1126\/science.1233765","volume":"340","author":"SK Mishra","year":"2013","unstructured":"Mishra SK, Hoon MA (2013) The cells and circuitry for itch responses in mice. Science 340:968\u2013971","journal-title":"Science"},{"key":"16_CR72","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-2210-12-5","volume":"12","author":"TA Munro","year":"2012","unstructured":"Munro TA, Berry LM, Van\u2019t Veer A, B\u00e9guin C, Carroll FI, Zhao Z, Carlezon WA, Cohen BM (2012) Long-acting \u03ba opioid antagonists nor-BNI, GNTI and JDTic: pharmacokinetics in mice and lipophilicity. BMC Pharmacol 12:5","journal-title":"BMC Pharmacol"},{"issue":"8","key":"16_CR73","doi-asserted-by":"crossref","first-page":"e70701","DOI":"10.1371\/journal.pone.0070701","volume":"8","author":"TA Munro","year":"2013","unstructured":"Munro TA, Huang X-P, Inglese C, Perrone MG, Van\u2019t Veer A, Carroll FI, B\u00e9guin C, Carlezon WA, Colabufo NA, Cohen BM, Roth BL (2013) Selective \u03ba opioid antagonists nor-BNI, GNTI and JDTic have low affinities for non-opioid receptors and transporters. PLoS One 8(8):e70701","journal-title":"PLoS One"},{"key":"16_CR74","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1248\/cpb.46.366","volume":"46","author":"H Nagase","year":"1998","unstructured":"Nagase H, Hayakawa J, Kawamura K, Kawai K, Takezawa Y, Matsuura H, Tajima C, Endo T (1998) Discovery of a structurally novel opioid kappa-agonist derived from 4,5-epoxymorphinan. Chem Pharm Bull (Tokyo) 46:366\u2013369","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"16_CR75","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1358\/dot.2009.45.5.1377595","volume":"45","author":"K Nakao","year":"2009","unstructured":"Nakao K, Mochizuki H (2009) Nalfurafine hydrochloride: a new drug for the treatment of uremic pruritus in hemodialysis patients. Drugs Today 45:323\u2013329","journal-title":"Drugs Today"},{"key":"16_CR76","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ejphar.2012.08.017","volume":"695","author":"K Nakao","year":"2012","unstructured":"Nakao K, Togashi Y, Honda T, Momen S, Umeuchi H, Sakakibara S, Tanaka T, Okano K, Mochizuki H (2012) In vitro and in vivo pharmacological characterization of the main metabolites of nalfurafine hydrochloride. Eur J Pharmacol 695:57\u201361","journal-title":"Eur J Pharmacol"},{"key":"16_CR77","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/00002826-199619050-00009","volume":"19","author":"AC Pande","year":"1996","unstructured":"Pande AC, Pyke RE, Greiner M, Wideman GL, Benjamin R, Pierce MW (1996) Analgesic efficacy of enadoline versus placebo or morphine in postsurgical pain. Clin Neuropharmacol 19:451\u2013456","journal-title":"Clin Neuropharmacol"},{"issue":"14","key":"16_CR78","doi-asserted-by":"crossref","first-page":"4500","DOI":"10.1021\/jm050105i","volume":"48","author":"Kshitij A. Patkar","year":"2005","unstructured":"Patkar KA, Yan X, Murray TF, Aldrich JV (2005) [N\u03b1-BenzylTyr1, cyclo(D-Asp5, Dap8)]-dynorphin A-(1\u201311)NH2 cyclized in the \u201caddress\u201d domain is a novel \u03ba-opioid receptor antagonist. J Med Chem 48:4500\u20134503","journal-title":"Journal of Medicinal Chemistry"},{"key":"16_CR79","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1124\/jpet.113.206086","volume":"346","author":"KA Patkar","year":"2013","unstructured":"Patkar KA, Wu J, Ganno ML, Singh HD, Ross NC, Rasakham K, Toll L, McLaughlin JP (2013) Physical presence of nor-binaltorphimine in mouse brain over 21 days after a single administration corresponds to its long-lasting antagonistic effect on \u03ba-opioid receptors. J Pharmacol Exp Ther 346:545\u2013554","journal-title":"J Pharmacol Exp Ther"},{"key":"16_CR80","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0022-3565(25)27913-7","volume":"160","author":"J Pearl","year":"1968","unstructured":"Pearl J, Aceto MD, Harris LS (1968) Prevention of writhing and other effects of narcotics and narcotic antagonists in mice. J Pharmacol Exp Ther 160:217\u2013230","journal-title":"J Pharmacol Exp Ther"},{"key":"16_CR81","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1126\/science.3016896","volume":"233","author":"A Pfeiffer","year":"1986","unstructured":"Pfeiffer A, Brantl V, Herz A, Emrich HM (1986) Psychotomimesis mediated by \u03ba opiate receptors. Science 233:774\u2013776","journal-title":"Science"},{"key":"16_CR82","doi-asserted-by":"crossref","first-page":"555","DOI":"10.2340\/00015555-1353","volume":"92","author":"NQ Phan","year":"2012","unstructured":"Phan NQ, Lotts T, Antal A, Bernhard JD, St\u00e4nder S (2012) Systemic kappa opioid receptor agonists in the treatment of chronic pruritus: a literature review. Acta Derm Venereol 92:555\u2013560","journal-title":"Acta Derm Venereol"},{"key":"16_CR83","first-page":"231","volume":"220","author":"AW Pircio","year":"1976","unstructured":"Pircio AW, Gylys JA, Cavanagh RL, Buyniski JP, Bierwagen ME (1976) The pharmacology of butorphanol, a 3,14-dihydroxymorphinan narcotic antagonist analgesic. Arch Int Pharmacodyn Ther 220:231\u2013257","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"16_CR84","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/0024-3205(87)90585-6","volume":"40","author":"PS Portoghese","year":"1987","unstructured":"Portoghese PS, Lipkowski AW, Takemori AE (1987) Binaltorphimine and nor-binaltorphimine, potent and selective \u03ba-opioid receptor antagonists. Life Sci 40:1287\u20131292","journal-title":"Life Sci"},{"key":"16_CR85","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0014-2999(88)90502-X","volume":"146","author":"PS Portoghese","year":"1988","unstructured":"Portoghese PS, Sultana M, Takemori AE (1988) Naltrindole, a highly selective and potent non-peptide delta opioid receptor antagonist. Eur J Pharmacol 146:185\u2013186","journal-title":"Eur J Pharmacol"},{"key":"16_CR86","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1021\/jm00168a028","volume":"33","author":"PS Portoghese","year":"1990","unstructured":"Portoghese PS, Sultana M, Takemori AE (1990) Design of peptidomimetic delta opioid receptor antagonists using the message-address concept. J Med Chem 33:1714\u20131720","journal-title":"J Med Chem"},{"key":"16_CR87","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1002\/j.1552-4604.1994.tb01991.x","volume":"34","author":"PA Reece","year":"1994","unstructured":"Reece PA, Sedman AJ, Rose S, Wright DS, Dawkins R, Rajagopalan R (1994) Diuretic effects, pharmacokinetics, and safety of a new centrally acting kappa-opioid agonist (CI-977) in humans. J Clin Pharmacol 34:1126\u20131132","journal-title":"J Clin Pharmacol"},{"key":"16_CR88","doi-asserted-by":"crossref","first-page":"27050","DOI":"10.1074\/jbc.C112.387332","volume":"287","author":"M-L Rives","year":"2012","unstructured":"Rives M-L, Rossillo M, Liu-Chen L-Y, Javitch JA (2012) 6\u2032-Guanidinonaltrindole (6\u2032-GNTI) is a G protein-biased \u03ba-opioid receptor agonist that inhibits arrestin recruitment. J Biol Chem 287:27050\u201327054","journal-title":"J Biol Chem"},{"key":"16_CR89","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1476-5381.1992.tb14413.x","volume":"106","author":"H Rogers","year":"1992","unstructured":"Rogers H, Birch PJ, Harrison SM, Palmer E, Manchee GR, Judd DB, Naylor A, Scopes DIC, Hayes AG (1992) GR94839, a \u03ba-opioid agonist with limited access to the central nervous system, has antinociceptive activity. Br J Pharmacol 106:783\u2013789","journal-title":"Br J Pharmacol"},{"key":"16_CR90","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0024-3205(80)90107-1","volume":"27","author":"D R\u00f6mer","year":"1980","unstructured":"R\u00f6mer D, B\u00fcscher H, Hill RC, Maurer R, Petcher TJ, Welle HBA, Bakel HCCK, Akkerman M (1980) Bremazocine: a potent, long-acting opiate kappa-agonist. Life Sci 27:971\u2013978","journal-title":"Life Sci"},{"key":"16_CR91","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/298759a0","volume":"298","author":"D R\u00f6mer","year":"1982","unstructured":"R\u00f6mer D, B\u00fcscher HH, Hill RC, Maurer R, Petcher TJ (1982) An opioid benzodiazepine. Nature 298:759\u2013760","journal-title":"Nature"},{"key":"16_CR92","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.biopsych.2013.07.042","volume":"76","author":"SE Russell","year":"2014","unstructured":"Russell SE, Rachlin AB, Smith KL, Muschamp J, Berry L, Zhao Z, Chartoff EH (2014) Sex differences in sensitivity to the depressive-like effects of the kappa opioid receptor agonist U-50488 in rats. Biol Psychiatry 76:213\u2013222","journal-title":"Biol Psychiatry"},{"key":"16_CR93","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0376-8716(85)90066-3","volume":"14","author":"WK Schmidt","year":"1985","unstructured":"Schmidt WK, Tam SW, Shotzberger GS, Smith DH, Clark R, Vernier VG (1985) Nalbuphine. Drug Alcohol Depend 14:339\u2013362","journal-title":"Drug Alcohol Depend"},{"key":"16_CR94","doi-asserted-by":"crossref","first-page":"276A","DOI":"10.1681\/ASN.2013010069","volume":"25","author":"T Sciascia","year":"2014","unstructured":"Sciascia T, Hait H, Berg JK, Alcorn H, Hawi A (2014) Exploring clinical and pharmacological effects of nalbuphine HCl oral tablets in hemodialysis subjects with pruritus. J Am Soc Nephrol 25:276A","journal-title":"J Am Soc Nephrol"},{"key":"16_CR95","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/j.1476-5381.1989.tb11911.x","volume":"96","author":"JS Shaw","year":"1989","unstructured":"Shaw JS, Carroll JA, Alcock P, Main BG (1989) ICI 204448: a \u03ba-opioid agonist with limited access to the CNS. Br J Pharmacol 96:986\u2013992","journal-title":"Br J Pharmacol"},{"key":"16_CR96","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1523\/JNEUROSCI.2955-14.2015","volume":"35","author":"C Solorzano","year":"2015","unstructured":"Solorzano C, Villafuerte D, Meda K, Cevikbas F, Br\u00e1z J, Sharif-Naeini R, Juarez-Salinas D, Llewellyn-Smith IJ, Guan Z, Basbaum AI (2015) Primary afferent and spinal cord expression of gastrin-releasing peptide: message, protein, and antibody concerns. J Neurosci 35:648\u2013657","journal-title":"J Neurosci"},{"key":"16_CR97","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0014-2999(94)00449-8","volume":"264","author":"R Spanagel","year":"1994","unstructured":"Spanagel R, Almeida OFX, Shippenberg TS (1994) Evidence that nor-binaltorphimine can function as an antagonist at multiple opioid receptor subtypes. Eur J Pharmacol 264:157\u2013162","journal-title":"Eur J Pharmacol"},{"key":"16_CR98","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1021\/jm0000665","volume":"43","author":"WC Stevens","year":"2000","unstructured":"Stevens WC, Jones RM, Subramanian G, Metzger TG, Ferguson DM, Portoghese PS (2000) Potent and selective indolomorphinan antagonists of the kappa-opioid receptor. J Med Chem 43:2759\u20132769","journal-title":"J Med Chem"},{"key":"16_CR99","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1124\/jpet.111.178970","volume":"337","author":"P-Y Su","year":"2011","unstructured":"Su P-Y, Ko M-C (2011) The role of central gastrin-releasing peptide and neuromedin B receptors in the modulation of scratching behavior in rats. J Pharmacol Exp Ther 337:822\u2013829","journal-title":"J Pharmacol Exp Ther"},{"key":"16_CR100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(98)00288-X","volume":"351","author":"Y Sugimoto","year":"1998","unstructured":"Sugimoto Y, Umakoshi K, Nojiri N, Kamei C (1998) Effects of histamine H1 receptor antagonists on compound 48\/80-induced scratching behavior in mice. Eur J Pharmacol 351:1\u20135","journal-title":"Eur J Pharmacol"},{"key":"16_CR101","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/nature06029","volume":"448","author":"Y-G Sun","year":"2007","unstructured":"Sun Y-G, Chen Z-F (2007) A gastrin-releasing peptide receptor mediates the itch sensation in the spinal cord. Nature 448:700\u2013703","journal-title":"Nature"},{"key":"16_CR102","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1126\/science.1174868","volume":"325","author":"Y-G Sun","year":"2009","unstructured":"Sun Y-G, Zhao Z-Q, Meng X-L, Yin J, Liu X-Y, Chen Z-F (2009) Cellular basis of itch sensation. Science 325:1531\u20131534","journal-title":"Science"},{"key":"16_CR200","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.brainres.2003.09.057","volume":"995","author":"T Suzuki","year":"2004","unstructured":"Suzuki T, Izumimoto N, Takezawa Y, Fujimura M, Togashi Y, Nagase H, Tanaka T, Endoh T (2004) Effect of repeated administration of TRK-820, a k-opioid receptor agonist, on tolerance to its antinociceptive and sedative effects. Brain Res 995:167\u2013175","journal-title":"Brain Res"},{"key":"16_CR103","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/978-3-0348-8730-4_4","volume":"52","author":"J Szmuszkovicz","year":"1999","unstructured":"Szmuszkovicz J (1999) U-50,488 and the \u03ba receptor: a personalized account covering the period 1973\u20131990. Prog Drug Res 52:167\u2013195","journal-title":"Prog Drug Res"},{"key":"16_CR104","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1080\/00015550152572868","volume":"81","author":"JS Thomsen","year":"2001","unstructured":"Thomsen JS, Petersen MB, Benfeldt E, Jensen SB, Serup J (2001) Scratch induction in the rat by intradermal serotonin: a model for pruritus. Acta Derm Venereol 81:250\u2013254","journal-title":"Acta Derm Venereol"},{"key":"16_CR105","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0014-2999(01)01588-6","volume":"435","author":"Y Togashi","year":"2002","unstructured":"Togashi Y, Umeuchi H, Okano K, Ando N, Yoshizawa Y, Honda T, Kawamura K, Endoh T, Utsumi J, Kamei J, Tanaka T, Nagase H (2002) Antipruritic activity of the \u03ba-opioid receptor agonist, TRK-820. Eur J Pharmacol 435:259\u2013264","journal-title":"Eur J Pharmacol"},{"key":"16_CR106","doi-asserted-by":"crossref","first-page":"823","DOI":"10.5414\/CP201852","volume":"51","author":"Y Ueno","year":"2013","unstructured":"Ueno Y, Mori A, Yanagita T (2013) One year long-term study on abuse liability of nalfurafine in hemodialysis patients. Int J Clin Pharmacol Ther 51:823\u2013831","journal-title":"Int J Clin Pharmacol Ther"},{"key":"16_CR107","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ejphar.2003.08.007","volume":"477","author":"H Umeuchi","year":"2003","unstructured":"Umeuchi H, Togashi Y, Honda T, Nakao K, Okano K, Tanaka T, Nagase H (2003) Involvement of central \u03bc-opioid system in the scratching behavior in mice, and the suppression of it by the activation of \u03ba-opioid system. Eur J Pharmacol 477:29\u201335","journal-title":"Eur J Pharmacol"},{"key":"16_CR108","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.coph.2009.09.007","volume":"10","author":"RM Van Rijn","year":"2010","unstructured":"Van Rijn RM, Whistler JL, Waldhoer M (2010) Opioid-receptor-heteromer-specific trafficking and pharmacology. Curr Opin Pharmacol 10:73\u201379","journal-title":"Curr Opin Pharmacol"},{"key":"16_CR109","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0014-2999(91)90010-N","volume":"209","author":"TB Van Wimersma Greidanus","year":"1991","unstructured":"Van Wimersma Greidanus TB, Maigret C (1991) Neuromedin-induced excessive grooming\/scratching behavior is suppressed by naloxone, neurotensin and a dopamine-1 receptor antagonist. Eur J Pharmacol 209:57\u201361","journal-title":"Eur J Pharmacol"},{"key":"16_CR110","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0196-9781(85)90097-X","volume":"6","author":"TB Van Wimersma Greidanus","year":"1985","unstructured":"Van Wimersma Greidanus TB, Donker DK, Van Zinnicq Bergmann FFM, Bekenkamp R, Maigret C, Spruijt B (1985a) Comparison between excessive grooming induced by bombesin or by ACTH: the differential elements of grooming and development of tolerance. Peptides 6:369\u2013372","journal-title":"Peptides"},{"key":"16_CR111","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/0196-9781(85)90447-4","volume":"6","author":"TB Van Wimersma Greidanus","year":"1985","unstructured":"Van Wimersma Greidanus TB, Donker DK, Walhof R, Van Grafhorst JCA, De Vries N, Van Schaik SJ, Maigret C, Spruijt BM, Colbern DL (1985b) The effects of neurotensin, naloxone and haloperidol on elements of excessive grooming behavior induced by bombesin. Peptides 6:1179\u20131183","journal-title":"Peptides"},{"key":"16_CR112","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0163-1047(86)90612-6","volume":"46","author":"TB Van Wimersma Greidanus","year":"1986","unstructured":"Van Wimersma Greidanus TB, Maigret C, Ten Haaf JA, Spruijt BM, Colbern DL (1986) The influence of neurotensin, naloxone, and haloperidol on elements of excessive grooming behavior induced by ACTH. Behav Neural Biol 46:137\u2013144","journal-title":"Behav Neural Biol"},{"key":"16_CR113","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0014-2999(87)90380-3","volume":"144","author":"TB Van Wimersma Greidanus","year":"1987","unstructured":"Van Wimersma Greidanus TB, Maigret C, Krechting B (1987) Excessive grooming induced by somatostatin or its analog SMS 201\u2013995. Eur J Pharmacol 144:277\u2013285","journal-title":"Eur J Pharmacol"},{"key":"16_CR114","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ejphar.2008.01.011","volume":"583","author":"TW Vanderah","year":"2008","unstructured":"Vanderah TW, Largent-Milnes T, Lai J, Porreca F, Houghten RA, Menzaghi F, Wisniewski K, Stalewski J, Sueiras-Diaz J, Galyean R, Schteingart C, Junien J-L, Trojnar J, Rivi\u00e8re PJ-M (2008) Novel D-amino acid tetrapeptides produce potent antinociception by selectively acting at peripheral \u03ba-opioid receptors. Eur J Pharmacol 583:62\u201372","journal-title":"Eur J Pharmacol"},{"key":"16_CR115","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0022-3565(25)21012-6","volume":"246","author":"PF Von Voigtlander","year":"1988","unstructured":"Von Voigtlander PF, Lewis RA (1988) Analgesic and mechanistic evaluation of spiradoline, a potent kappa opioid. J Pharmacol Exp Ther 246:259\u2013262","journal-title":"J Pharmacol Exp Ther"},{"key":"16_CR116","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0896-6273(91)90250-4","volume":"6","author":"E Wada","year":"1991","unstructured":"Wada E, Way J, Shapira H, Kusano K, Lebacq-Verheyden AM, Coy D, Jensen R, Battey J (1991) cDNA cloning, characterization, and brain region-specific expression of a neuromedin-B-preferring bombesin receptor. Neuron 6:421\u2013430","journal-title":"Neuron"},{"key":"16_CR117","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s002130100788","volume":"157","author":"SL Walsh","year":"2001","unstructured":"Walsh SL, Strain EC, Abreu ME, Bigelow GE (2001) Enadoline, a selective kappa opioid agonist: comparison with butorphanol and hydromorphone in humans. Psychopharmacology (Berl) 157:151\u2013162","journal-title":"Psychopharmacology (Berl)"},{"key":"16_CR118","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1124\/jpet.104.073668","volume":"312","author":"Y Wang","year":"2005","unstructured":"Wang Y, Tang K, Inan S, Siebert D, Holzgrabe U, Lee DYW, Huang P, Li J-G, Cowan A, Liu-Chen L-Y (2005) Comparison of pharmacological activities of three distinct \u03ba ligands (salvinorin A, TRK-820 and 3FLB) on \u03ba opioid receptors in vitro and their antipruritic and antinociceptive activities in vivo. J Pharmacol Exp Ther 312:220\u2013230","journal-title":"J Pharmacol Exp Ther"},{"key":"16_CR119","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/BF02244551","volume":"104","author":"H Wheeler-Aceto","year":"1991","unstructured":"Wheeler-Aceto H, Cowan A (1991) Standardization of the rat paw formalin test for the evaluation of analgesics. Psychopharmacology (Berl) 104:35\u201344","journal-title":"Psychopharmacology (Berl)"},{"key":"16_CR120","doi-asserted-by":"crossref","first-page":"3742","DOI":"10.1681\/ASN.2005020152","volume":"16","author":"B Wikstr\u00f6m","year":"2005","unstructured":"Wikstr\u00f6m B, Gellert R, Ladefoged SD, Danda Y, Akai M, Ide K, Ogasawara M, Kawashima Y, Ueno K, Mori A, Ueno Y (2005) \u03ba-Opioid system in uremic pruritus: multicenter, randomized, double-blind, placebo-controlled clinical studies. J Am Soc Nephrol 16:3742\u20133747","journal-title":"J Am Soc Nephrol"},{"key":"16_CR121","first-page":"481","volume-title":"Goodman & Gilman\u2019s The pharmacological basis of therapeutics","author":"TL Yaksh","year":"2011","unstructured":"Yaksh TL, Wallace MS (2011) Opioids, analgesia, and pain management. In: Brunton LL, Chabner BA, Knollmann BC (eds) Goodman & Gilman\u2019s The pharmacological basis of therapeutics, 12th edn. McGraw Hill, New York, pp 481\u2013525","edition":"12"},{"key":"16_CR122","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/jnr.23501","volume":"93","author":"Y Zhang","year":"2015","unstructured":"Zhang Y, Dun SL, Chen Y-H, Luo JJ, Cowan A, Dun NJ (2015) Scratching activates microglia in the mouse spinal cord. J Neurosci Res 93:466\u2013474","journal-title":"J Neurosci Res"}],"container-title":["Handbook of Experimental Pharmacology","Pharmacology of Itch"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-662-44605-8_16","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T00:25:52Z","timestamp":1747873552000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-662-44605-8_16"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"ISBN":["9783662446041","9783662446058"],"references-count":122,"URL":"https:\/\/doi.org\/10.1007\/978-3-662-44605-8_16","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-3-662-44605-8","asserted-by":"object"}]},"ISSN":["0171-2004","1865-0325"],"issn-type":[{"value":"0171-2004","type":"print"},{"value":"1865-0325","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}